Digitalised Biology
Ori Biotech Raises Over USD100M in Series B Funding
Ori Biotech Ltd., a London, UK- and and New Jersey-based leader in cell and gene therapy (CGT) manufacturing technology, secured over USD 100m in Series B funding. Founded in 2015 by Dr Farlan Veraitch (UCL) and led by Jason C. Foster, CEO, Ori provides a proprietary, full stack manufacturing system that closes, automates, digitizes and standardizes CGT manufacturing. It will enable therapy developers, contract manufacturers and academic researchers to transition from pre-clinical process discovery through clinical trials to commercial scale.
Ori Biotech Raises Over USD100M in Series B Funding
Ori Biotech Ltd., a London, UK- and and New Jersey-based leader in cell and gene therapy (CGT) manufacturing technology, secured over USD 100m in Series B funding
Medical start-up ProVerum receives €30m in Series A funding
The Trinity College Dublin spin-out is developing technology to treat benign prostatic hyperplasia (BPH), which is an enlargement of the prostate gland that causes difficulty with urination. Its ProVee device is a nitinol expander that gently re-shapes the enlarged prostate to alleviate the symptoms caused by BPH.
Amerson has more than 30 years’ experience in the development and commercialisation of novel medical devices in the field of urology and was previously CEO of medical equipment manufacturer Neotract.
Medical start-up ProVerum receives €30m in Series A funding
Irish start-up ProVerum has received FDA approval to trial its medical product after promising results in an Australian study.
MycoWorks Raises $125M in Series C Financing
Co-founded in 2013 by Philip Ross and Sophia Wang, and led by Matt Scullin, CEO, MycoWorks is a biomaterials company dedicated to bringing new mycelium materials to the world. Its patented Fine Mycelium technology, an advanced manufacturing platform, engineers mycelium during growth to form proprietary, interlocking cellular structures for strength and durability. The patented Fine Mycelium process produces natural material with the performance of the finest animal leathers and lower environmental impact. The biotechnology platform engineers mycelium to grow the only made-to-order, made-to-specification luxury material.
MycoWorks Raises $125M in Series C Financing - FinSMEs
MycoWorks, an Emeryville CA-based biomaterials company, raised $125M in Series C funding
Shanghai ZhenGe Biotech Raises USD100M in Series C Funding
Led by Mr. Jianxin Chen, Chairman and CEO, Shanghai ZhenGe Biotech provides Contract Development and Manufacturing Organization (CDMO) services and offers end-to-end solutions to help customers discover, develop, and manufacture biologics from concept to commercialization. It provides such services as: macromolecule developability analysis, cell line development, process development and optimization, pilot production, clinical sample production and commercial CMO services, process characterization and validation research, drug analysis services, cell culture medium formulation development and commercial production.
